Androcur
Last Updated on eMC 15-May-2017 View document | Bayer plc Contact details
Versions
- 15-May-2017 to Current
- 08-Aug-2016 to 15-May-2017
- 12-Oct-2015 to 08-Aug-2016
- 03-Jan-2013 to 12-Oct-2015
- 03-Feb-2011 to 03-Jan-2013
- 31-Jan-2011 to 03-Feb-2011
- 17-Jun-2010 to 31-Jan-2011
- 09-Jun-2010 to 17-Jun-2010
- 10-Sep-2009 to 09-Jun-2010
- 17-Aug-2009 to 10-Sep-2009
- 04-Jun-2008 to 17-Aug-2009
- 22-Sep-2006 to 04-Jun-2008
- 03-Sep-2004 to 22-Sep-2006
- 31-Aug-2004 to 03-Sep-2004
- 15-Jul-2002 to 31-Aug-2004
- 24-Jul-2001 to 15-Jul-2002
- 19-Jul-2000 to 24-Jul-2001
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 15-May-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 08-Aug-2016 and displayed until 15-May-2017
Reasons for adding or updating:
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Updated on 12-Oct-2015 and displayed until 08-Aug-2016
Reasons for adding or updating:
- Change to section 1 - what the product is
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - use in children/adolescents
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 2 - driving and using machines
- Change to section 2 - excipient warnings
- Change to section 3 - dose and frequency
- Change to section 3 - use in children/adolescents
- Change to section 3 - how to take/use
- Change to section 3 - duration of treatment
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 5 - how to store
- Change to section 6 - date of revision
Updated on 03-Jan-2013 and displayed until 12-Oct-2015
Reasons for adding or updating:
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 03-Feb-2011 and displayed until 03-Jan-2013
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
Updated on 31-Jan-2011 and displayed until 03-Feb-2011
Reasons for adding or updating:
- Change to date of revision
- Change of contra-indications
- Extra statutory information
Updated on 17-Jun-2010 and displayed until 31-Jan-2011
Reasons for adding or updating:
- Correction of spelling/typing errors
Updated on 09-Jun-2010 and displayed until 17-Jun-2010
Reasons for adding or updating:
- Change to dosage and administration
- Change to date of revision
Updated on 10-Sep-2009 and displayed until 09-Jun-2010
Reasons for adding or updating:
- Change to date of revision
- Change to warnings or special precautions for use
- Change to side-effects
Updated on 17-Aug-2009 and displayed until 10-Sep-2009
Reasons for adding or updating:
- Improved Electronic Presentation
- Change due to harmonisation of PIL.
- Change to date of revision
Updated on 04-Jun-2008 and displayed until 17-Aug-2009
Reasons for adding or updating:
- Change to date of revision
- Change of licence holder
- Change to Marketing Authorisation Holder
- Change to MA holder contact details
Updated on 22-Sep-2006 and displayed until 04-Jun-2008
Reasons for adding or updating:
- Change to date of revision
- Change of manufacturer
Updated on 03-Sep-2004 and displayed until 22-Sep-2006
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 31-Aug-2004 and displayed until 03-Sep-2004
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change of contra-indications
- Change to side-effects
- Change to date of revision
- Change to, or new, use for medicine
Updated on 15-Jul-2002 and displayed until 31-Aug-2004
Reasons for adding or updating:
- Update to PIL
Updated on 24-Jul-2001 and displayed until 15-Jul-2002
Reasons for adding or updating:
- Update to PIL
Updated on 19-Jul-2000 and displayed until 24-Jul-2001
Reasons for adding or updating:
- No reasons supplied
Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
+44 (0)1635 563 393
+44 (0)1635 563 000
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue